Management of cT4 Prostate Cancer

Weranja K.B. Ranasinghe; Chad A. Reichard; Tharakeswara Bathala; Brian F. Chapin

doi:10.1016/j.euf.2019.06.012

Management of cT4 Prostate Cancer

Weranja K.B. Ranasinghe, Chad A. Reichard, Tharakeswara Bathala, Brian F. Chapin

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

There is growing evidence of survival benefits from local therapy for cT4 prostate cancer, with radiotherapy and androgen deprivation therapy continuing to be the mainstays of treatment. Surgery may be considered as part of a multimodal treatment strategy with acceptable morbidity.

Original language	English (US)
Pages (from-to)	221-226
Number of pages	6
Journal	European Urology Focus
Volume	6
Issue number	2
DOIs	https://doi.org/10.1016/j.euf.2019.06.012
State	Published - Mar 15 2020

Keywords

Locally advanced prostate cancer
Management
Prostate cancer
Treatment
cT4
t4

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.euf.2019.06.012

Cite this

@article{329208232a0e420d9799843404248ca7,

title = "Management of cT4 Prostate Cancer",

abstract = "There is growing evidence of survival benefits from local therapy for cT4 prostate cancer, with radiotherapy and androgen deprivation therapy continuing to be the mainstays of treatment. Surgery may be considered as part of a multimodal treatment strategy with acceptable morbidity.",

keywords = "Locally advanced prostate cancer, Management, Prostate cancer, Treatment, cT4, t4",

author = "Ranasinghe, {Weranja K.B.} and Reichard, {Chad A.} and Tharakeswara Bathala and Chapin, {Brian F.}",

note = "Publisher Copyright: {\textcopyright} 2019 European Association of Urology",

year = "2020",

month = mar,

day = "15",

doi = "10.1016/j.euf.2019.06.012",

language = "English (US)",

volume = "6",

pages = "221--226",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Management of cT4 Prostate Cancer

AU - Ranasinghe, Weranja K.B.

AU - Reichard, Chad A.

AU - Bathala, Tharakeswara

AU - Chapin, Brian F.

PY - 2020/3/15

Y1 - 2020/3/15

N2 - There is growing evidence of survival benefits from local therapy for cT4 prostate cancer, with radiotherapy and androgen deprivation therapy continuing to be the mainstays of treatment. Surgery may be considered as part of a multimodal treatment strategy with acceptable morbidity.

AB - There is growing evidence of survival benefits from local therapy for cT4 prostate cancer, with radiotherapy and androgen deprivation therapy continuing to be the mainstays of treatment. Surgery may be considered as part of a multimodal treatment strategy with acceptable morbidity.

KW - Locally advanced prostate cancer

KW - Management

KW - Prostate cancer

KW - Treatment

KW - cT4

KW - t4

UR - http://www.scopus.com/inward/record.url?scp=85067955075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067955075&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2019.06.012

DO - 10.1016/j.euf.2019.06.012

M3 - Review article

C2 - 31266732

AN - SCOPUS:85067955075

SN - 2405-4569

VL - 6

SP - 221

EP - 226

JO - European Urology Focus

JF - European Urology Focus

IS - 2

ER -

Management of cT4 Prostate Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this